SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-353381
Filing Date
2014-09-25
Accepted
2014-09-25 17:32:06
Documents
5
Period of Report
2014-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d794900d8k.htm 8-K 17587
2 EX-99.1 d794900dex991.htm EX-99.1 21451
3 EX-99.2 d794900dex992.htm EX-99.2 6319
4 GRAPHIC g794900snap0003.jpg GRAPHIC 2176
5 GRAPHIC g794900snap7940002.jpg GRAPHIC 5446
  Complete submission text file 0001193125-14-353381.txt   57660
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 141121418
SIC: 2834 Pharmaceutical Preparations